The prevalence and clinical characteristics of glucose metabolism disorders in patients with liver cirrhosis. A prospective study

Aims. To define the prevalence and clinical characteristics of glucose metabolism disorders (GMD) in patients with compensated liver cirrhosis (LC). Material and methods. Fasting plasma glucose (FPG) levels were measured...

A phase 2 study of filibuvir in combination with pegylated IFN alfa and ribavirin for chronic HCV

Objectives. Filibuvir is a non-nucleoside inhibitor of hepatitis C virus (HCV) polymerase. This study evaluated the safety and efficacy of filibuvir plus pegylated interferon alfa-2a (pegIFN)/ribavirin. Material and meth...

A giant calcified hepatic mass

Management of gastroesophageal varices in cirrhotic patients: current status and future directions

Bleeding from gastroesophageal varices (GEV) is a serious event in cirrhotic patients and can cause death. According to the explosión theory, progressive portal hypertension is the primary mechanism underlying variceal...

Estimated time from clinical presentation to the development of cirrhosis in non-cirrhotic adult patients with non-alcoholic fatty liver disease